Press Resease

Biosimulation Market - Global Industry Analysis

Biosimulation Market by Product (Software and Services), by Application (Drug Development, Drug Discovery, and Others), and by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Regulatory Authorities, and Academic Research Institutions): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 01-Apr-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-822 Status : Published

Global biosimulation market expected to generate around USD 4.58 billion by 2025, at a CAGR of around 15.7% between 2019 and 2025. Biosimulation is a biomedical research approach for patient treatment, where computer modeling is utilized along with clinical and experimental trials.

Description

The report covers a forecast and an analysis of the biosimulation market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the biosimulation market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the biosimulation market on a global level.

In order to give the users of this report a comprehensive view of the biosimulation market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Biosimulation Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the biosimulation market based on product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on product, the market is segmented into services and software. The services segment is further classified into contract services and in-house services. By application, the market includes drug discovery, drug development, and others. By end-user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, regulatory authorities, and academic research institutions. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global biosimulation market include Dassault Systèmes SE, Certara USA, Inc., Chemical Computing Group, Physiomics, In Silico Biosciences, INOSIM Software, Advanced Chemistry Development, Inc., Schrodinger, Inc., Genedata AG, and Rhenovia Pharma Ltd., among others.

This report segments the global biosimulation market as follows:

Global Biosimulation Market: Product Analysis

  • Software
  • Services 
    • In-House Services
    • Contract Services

Global Biosimulation Market: Application Analysis

  • Drug Development
  • Drug Discovery
  • Others

Global Biosimulation Market: End-User Analysis

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Regulatory Authorities
  • Academic Research Institutions

Global Biosimulation Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Biosimulation Market, 2017-2025 (USD Billion)
    • 2.2. Global Biosimulation Market: Snapshot
  •  
  • Chapter 3. Biosimulation Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Biosimulation Market drivers: Impact analysis
      • 3.2.2. Increase in R&D Investments in Pharmaceutical and Biotechnology Industries
      • 3.2.3. Growing Adoption of Biosimulation Software By Regulatory Bodies
      • 3.2.4. Technologically Advanced QSP Systems
    • 3.3. Market Restraints
      • 3.3.1. Global Biosimulation Market restraints: Impact analysis
      • 3.3.2. High product cost
      • 3.3.3. Lack of Standardization
    • 3.4. Opportunities
      • 3.4.1. Emerging Applications
      • 3.4.2. Increased Use of Personalized Medicines
      • 3.4.3. Use of Biosimulation Solution for Pediatric Drug Development
    • 3.5. Porter's Five Forces analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product
      • 3.6.2. Market attractiveness analysis, by application
      • 3.6.3. Market attractiveness analysis, by end-user
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Biosimulation Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Biosimulation Market: company market share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapy Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Technology Portfolio
  •  
  • Chapter 5. Global Biosimulation Market - Product Analysis
    • 5.1. Global Biosimulation Market: Product overview
      • 5.1.1. Global Biosimulation Market revenue share, by product, 2018 and 2025
    • 5.2. Software
      • 5.2.1. Global Software Market, 2017-2025 (USD Billion)
    • 5.3. Services
      • 5.3.1. Global Services market, 2017-2025 (USD Billion)
      • 5.3.2. Global In-house Services market, 2017-2025 (USD Billion)
      • 5.3.3. Global Contract Services market, 2017-2025 (USD Billion)
  •  
  • Chapter 6. Global Biosimulation Market - Application Analysis
    • 6.1. Global Biosimulation Market: Application overview
      • 6.1.1. Global Biosimulation Market revenue share, by application, 2017- 2025
    • 6.2. Drug Development
      • 6.2.1. Global Biosimulation Market for Drug Development, 2017-2025 (USD Billion)
    • 6.3. Drug Discovery
      • 6.3.1. Global Biosimulation Market for Drug Discovery, 2017-2025 (USD Billion)
    • 6.4. Others
      • 6.4.1. Global Biosimulation Market for Others, 2017-2025 (USD Billion)
  •  
  • Chapter 7. Global Biosimulation Market - End-user Analysis
    • 7.1. Global Biosimulation Market: End-user overview
      • 7.1.1. Global Biosimulation Market revenue share, by end-user, 2017 and 2025
    • 7.2. Pharmaceutical & Biotechnology Companies
      • 7.2.1. Global Biosimulation Market for Pharmaceutical & Biotechnology Companies, 2017-2025 (USD Billion)
    • 7.3. Contract Research Organizations
      • 7.3.1. Global Biosimulation Market for Contract Research Organizations, 2017-2025 (USD Billion)
    • 7.4. Regulatory Authorities
      • 7.4.1. Global Biosimulation Market for Regulatory Authorities, 2017-2025 (USD Billion)
    • 7.5. Academic Research Institutions
      • 7.5.1. Global Biosimulation Market for Academic Research Institutions, 2017-2025 (USD Billion)
  •  
  • Chapter 8. Global Biosimulation Market - Regional Analysis
    • 8.1. Global Biosimulation Market: Regional overview
      • 8.1.1. Global Biosimulation Market revenue share, by region, 2017 and 2025
    • 8.2. North America
      • 8.2.1. North America Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
      • 8.2.2. North America Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
      • 8.2.3. North America Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.2.4.2. The U.S. Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.2.4.3. The U.S. Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.2.5. Canada
        • 8.2.5.1. Canada Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.2.5.2. Canada Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.2.5.3. Canada Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
      • 8.3.2. Europe Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
      • 8.3.3. Europe Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.3.4.2. Germany Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.3.4.3. Germany Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.3.5. France
        • 8.3.5.1. France Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.3.5.2. France Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.3.5.3. France Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.3.6. UK
        • 8.3.6.1. UK Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.3.6.2. UK Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.3.6.3. UK Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.3.7.2. Rest of Europe Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.3.7.3. Rest of Europe Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
      • 8.4.2. Asia Pacific Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
      • 8.4.3. Asia Pacific Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.4.4.2. China Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.4.4.3. China Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.4.5.2. Japan Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.4.5.3. Japan Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.4.6.2. India Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.4.6.3. India Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
      • 8.5.2. Latin America Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
      • 8.5.3. Latin America Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.5.4.2. Brazil Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.5.4.3. Brazil Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
        • 8.5.5.2. Rest of Latin America Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
        • 8.5.5.3. Rest of Latin America Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Biosimulation Market revenue, by product, 2017-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa Biosimulation Market revenue, by application, 2017-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa Biosimulation Market revenue, by end-user, 2017-2025 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Dassault Systèmes SE
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Certara USA, Inc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Chemical Computing Group
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Physiomics
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. In Silico Biosciences
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. INOSIM Software
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Advanced Chemistry Development, Inc.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Schrodinger, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Genedata AG
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Rhenovia Pharma Ltd.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

List of Figures

1. Market research process
2. Market research methodology
3. Global Biosimulation Market revenue, 2017–2025 (USD Billion)
4. Porter’s Five Forces analysis
5. Biosimulation Market attractiveness analysis, by product
6. Biosimulation: Market attractiveness analysis, by application
7. Biosimulation: Market attractiveness analysis, by end-user
8. Biosimulation: Market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global Biosimulation Market revenue share by product, 2018 and 2025
11. Global Software Market, 2017–2025 (USD Billion)
12. Global Services market, 2017–2025 (USD Billion)
13. Global Biosimulation Market revenue share by application, 2017 and 2025
14. Global Biosimulation Market for Drug Development, 2017–2025 (USD Billion) 
15. Global Biosimulation Market for Drug Discovery, 2017–2025 (USD Billion) 
16. Global Biosimulation Market for Others, 2017–2025 (USD Billion) 
17. Global Biosimulation Market revenue share by end-user, 2017 and 2025
18. Global Biosimulation Market for Pharmaceutical & Biotechnology Companies, 2017–2025 (USD Billion) 
19. Global Biosimulation Market for Contract Research Organizations, 2017–2025 (USD Billion) 
20. Global Biosimulation Market for Regulatory Authorities, 2017–2025 (USD Billion)
21. Global Biosimulation Market for Academic Research Institutions, 2017–2025 (USD Billion)


List of Tables

1. Biosimulation Market: Market Snapshot                                                                                                                        
2. Drivers of global Biosimulation Market: Impact analysis 
3. Restraints of global Biosimulation Market: Impact analysis  
4. North America Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
5. North America Biosimulation Market revenue, by application, 2017–2025 (USD Billion) 
6. North America Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion) 
7. The U.S. Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
8. The U.S. Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
9. The U.S. Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
10. Canada Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
11. Canada Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
12. Canada Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
13. Europe Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
14. Europe Biosimulation Market revenue, by application, 2017–2025 (USD Billion) 
15. Europe Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
16. UK Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
17. UK Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
18. UK Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
19. Germany Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
20. Germany Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
21. Germany Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
22. France Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
23. France Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
24. France Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
25. Rest of Europe Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
26. Rest of Europe Biosimulation Market revenue, by application, 2017–2025 (USD Billion) 
27. Rest of Europe Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
28. Asia Pacific Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
29. Asia Pacific Biosimulation Market revenue, by application, 2017–2025 (USD Billion) 
30. Asia Pacific Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
31. China Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
32. China Biosimulation Market revenue, by application, 2017–2025 (USD Billion) 
33. China Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
34. Japan Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
35. Japan Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
36. Japan Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
37. India Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
38. India Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
39. India Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
40. Rest of Asia Pacific Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
41. Rest of Asia Pacific Biosimulation Market revenue, by application, 2017–2025 (USD Billion) 
42. Rest of Asia Pacific Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
43. Latin America Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
44. Latin America Biosimulation Market revenue, by application, 2017–2025 (USD Billion) 
45. Latin America Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
46. Brazil Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
47. Brazil Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
48. Brazil Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
49. Rest of Latin America Biosimulation Market revenue, by product, 2017–2025 (USD Billion) 
50. Rest of Latin America Biosimulation Market revenue, by application, 2017–2025 (USD Billion) 
51. Rest of Latin America Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)
52. The Middle East and Africa Biosimulation Market revenue, by product, 2017–2025 (USD Billion)
53. The Middle East and Africa Biosimulation Market revenue, by application, 2017–2025 (USD Billion)
54. The Middle East and Africa Biosimulation Market revenue, by end-user, 2017–2025 (USD Billion)

Methodology

Free Analysis

Biosimulation is a biomedical research approach for patient treatment, where computer modeling is utilized along with clinical and experimental trials. It is referred to as a tool used for prediction of the outcomes of existing trials associated with innovation and new drug development. The extensive need for advanced-generation therapeutics due to the rise in the occurrences of chronic diseases, such as diabetes and cancer, will fuel the growth of the global biosimulation market over the forecast timeline.

The development of improved technology, adoption of advanced software, and rising expenditure on healthcare will prominently boost the biosimulation market growth globally over the forecast time period. High clinical urgency to develop and discover advanced and high potency drugs are also estimated to play a crucial role in the growth of the global biosimulation market in the future. The other influencing factors, such as the rising healthcare expenditure and increasing adoption of advanced technology and software, will also support the global biosimulation market growth over the estimated time period.

Global Biosimulation Market

The global biosimulation market is segmented on the basis of product, application, and end-user. Based on product, the market is segmented into services and software. The services segment is further classified into contract services and in-house services. The services segment is expected to register the highest growth rate over the estimated time period, owing to the aggregate complexities and multi-layered drug development systems. By application, the market includes drug discovery, drug development, and others. The drug discovery segment is anticipated to grow at a noteworthy rate, owing to the increasing adoption of biosimulation in pharmacogenetics and pharmacogenomics over the forecast timeline. By end-user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, regulatory authorities, and academic research institutions. The contract research organizations segment is estimated to register the highest growth rate in the future.

By region, North America is projected to dominate the global biosimulation market throughout the forecast time period, owing to a large number of clinical trials and drug development practices, increasing growth of pharmaceutical and biotechnology companies, and growing adoption of personalized medicines. Europe held the second largest share of the global biosimulation market in 2018. The Asia Pacific biosimulation market is expected to grow rapidly over the forecast timeline, owing to the increasing preference for contract research organizations, developing healthcare infrastructure, and rising expenditure in the healthcare IT sector. Latin America and the Middle East and Africa are expected to experience moderate market growth in the years to come.

Some key players of the global biosimulation market include Dassault Systèmes SE, Certara USA, Inc., Chemical Computing Group, Physiomics, In Silico Biosciences, INOSIM Software, Advanced Chemistry Development, Inc., Schrodinger, Inc., Genedata AG, and Rhenovia Pharma Ltd., among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed